Since higher levels of functional markers associated with IFN-γ expression (IL-10, CD317) are seen in BalbY with the best survival, it could be beneficial to design influenza vaccines that target a Th1 immune response, particularly in individuals who lack robust Th1 immunity. The gene discussed is IL10; the disease is influenza.